Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Gefapixant Citrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,459Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions
    Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions

    28 Mar 2024

    // PRESS RELEASE

    https://www.tantuchemicals.com/news/revarazan-hcl-for-acute-gastritis-chronic-gas-76202020.html

    PRESS RELEASE
    28 Mar 2024
    Share Share
    GEFAPIXAN CITRATE-Effective Suppression Of Chronic Cough
    GEFAPIXAN CITRATE-Effective Suppression Of Chronic Cough

    13 Mar 2024

    // PRESS RELEASE

    https://www.tantuchemicals.com/news/gefapixan-citrate-effective-suppression-of-chr-75813172.html

    PRESS RELEASE
    13 Mar 2024
    Share Share
    US FDA declines to approve Merck's chronic cough drug
    US FDA declines to approve Merck's chronic cough drug

    21 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231220302305/en/Merck-Provides-U.S.-Regulatory-Update-on-Gefapixant

    BUSINESSWIRE
    21 Dec 2023
    Share Share
    FDA panel flags insufficient data for Merck's chronic cough drug
    FDA panel flags insufficient data for Merck's chronic cough drug

    18 Nov 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-mercks-chronic-cough-drug-2023-11-17/

    REUTERS
    18 Nov 2023
    Share Share
    US FDA staff flags concerns about Merck's chronic cough drug
    US FDA staff flags concerns about Merck's chronic cough drug

    16 Nov 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flags-concerns-mercks-chronic-cough-drug-2023-11-15/

    REUTERS
    16 Nov 2023
    Share Share
    FDA skeptical of Merck’s gefapixant, even after cough recount
    FDA skeptical of Merck’s gefapixant, even after cough recount

    16 Nov 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ahead-tomorrows-adcomm-fda-skeptical-mercks-gefapixant-even-after-pharma-recounted-coughs

    Gabrielle Masson FIERCE BIOTECH
    16 Nov 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.